Reaction Details Report a problem with these data
Target
Sepiapterin reductase
Ligand
BDBM187261
Substrate
n/a
Meas. Tech.
Chromogenic assay
pH
6.5±n/a
Temperature
310.15±n/a K
IC50
2100±n/a nM
Comments
extracted
Citation
 Blagg, J Sepiapterin reductase inhibitors for the treatment of pain US Patent  US9169234 Publication Date 10/27/2015 
Target
Name:
Sepiapterin reductase
Synonyms:
SPR | SPRE_HUMAN | Sepiapterin reductase (SPR)
Type:
Enzyme
Mol. Mass.:
28050.66
Organism:
Homo sapiens (Human)
Description:
P35270
Residue:
261
Sequence:
MEGGLGRAVCLLTGASRGFGRTLAPLLASLLSPGSVLVLSARNDEALRQLEAELGAERSGLRVVRVPADLGAEAGLQQLLGALRELPRPKGLQRLLLINNAGSLGDVSKGFVDLSDSTQVNNYWALNLTSMLCLTSSVLKAFPDSPGLNRTVVNISSLCALQPFKGWALYCAGKAARDMLFQVLALEEPNVRVLNYAPGPLDTDMQQLARETSVDPDMRKGLQELKAKGKLVDCKVSAQKLLSLLEKDEFKSGAHVDFYDK
  
Inhibitor
Name:
BDBM187261
Synonyms:
US9169234, 12
Type:
Small organic molecule
Emp. Form.:
C15H15N3O
Mol. Mass.:
253.2991
SMILES:
Oc1ccc2[nH]cc(CCNc3cccnc3)c2c1
Structure:
Search PDB for entries with ligand similarity: